Kamran M. Mirza
Expertise in
2
conditions
Expertise in
2
conditions
1500 E Medical Center Dr, 
Ann Arbor, MI 

Overview

Kamran Mirza is a Hematologist practicing medicine in Ann Arbor, Michigan.

Dr. Mirza is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Acute Myeloid Leukemia (AML), Virus Associated Hemophagocytic Syndrome, and Reticulohistiocytoma.

He is actively involved in clinical research, co-authoring 72 peer reviewed articles. Dr. Mirza is currently accepting new patients.

Graduate Institution

Aga Khan University Medical College, 2003

Specialties

Hematology

Licenses

Anatomic Pathology & Clinical Pathology in IL

Fellowships

University of Chicago Hospitals, Hematopathology, 2013

Hospital Affiliations

Mercy St Vincent Medical Center
University Of Michigan Health System

Languages Spoken

English
Urdu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO

Locations

U of M Pathology
1500 E Medical Center Dr, Ann Arbor, MI 48109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Similar Doctors
Expertise in
33
conditions
Hematology | Oncology | Pediatrics
Expertise in
33
conditions
Hematology | Oncology | Pediatrics
Referral may be required

Rogel Cancer Center

1500 E Medical Center Dr, Floor B1 Reception A, 
Ann Arbor, MI 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.

Expertise in
35
conditions
Hematology | Oncology
Expertise in
35
conditions
Hematology | Oncology
Referral may be required

C. S. Mott Children's Hospital

1540 E Hospital Dr, Floor 7 Reception B, 
Ann Arbor, MI 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients

Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology. Dr. Bixby is currently accepting new patients.

Expertise in
36
conditions
Hematology | Oncology
Expertise in
36
conditions
Hematology | Oncology
Referral may be required

University Of Michigan Medical Center

1500 E Medical Center Dr, 
Ann Arbor, MI 
 (0.1 miles away)
Languages Spoken:
English, Hindi
Accepting New Patients

Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Neuroepithelioma, and Bone Marrow Aspiration. Dr. Mody is currently accepting new patients.

Frequently Asked Questions about Dr. Kamran M. Mirza

How do I make an appointment with Dr. Kamran M. Mirza?

You can book an appointment with Dr. Kamran M. Mirza by calling their office at 734-936-4000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kamran M. Mirza a top-rated expert for Hemophagocytic Lymphohistiocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kamran M. Mirza is classified as an Advanced expert for Hemophagocytic Lymphohistiocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kamran M. Mirza specialize in?

While Dr. Kamran M. Mirza is a Hematology, they have specific expertise in Hemophagocytic Lymphohistiocytosis, Acute Myeloid Leukemia (AML), and Virus Associated Hemophagocytic Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Kamran M. Mirza participate in research or clinical trials?

Yes. Dr. Kamran M. Mirza has published 72 articles and abstracts on conditions like Hemophagocytic Lymphohistiocytosis. You can view a list of Dr. Kamran M. Mirza's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kamran M. Mirza accept my insurance?

Dr. Kamran M. Mirza accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 734-936-4000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mirza's expertise for a condition
ConditionClose
      View All 28 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile